1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Results 81-100 of 158 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
811-Sep-2021Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarksUpadhyay, Neha; Tilekar, Kalpana; Safuan, Sabreena; Kumar, Alan P ; Schweipert, Markus; Meyer-Almes, Franz-Josef; Ramaa, CS
82Feb-2012Multifaceted link between cancer and inflammationSethi, G.; Shanmugam, M.K. ; Ramachandran, L.; Kumar, A.P. ; Tergaonkar, V.
832018N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-?B signaling pathwayMohan, C.D; Bharathkumar, H; Dukanya, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, S; Shanmugam, M.K ; Chinnathambi, A; Alharbi, S.A; Alahmadi, T.A; Bhattacharjee, A; Lobie, P.E ; Deivasigamani, A; Hui, K.M; Sethi, G ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S; Kumar, A.P 
8417-Jun-2022(Nano)platforms in bladder cancer therapy: Challenges and opportunitiesAshrafizadeh, Milad; Zarrabi, Ali; Karimi-Maleh, Hassan; Taheriazam, Afshin; Mirzaei, Sepideh; Hashemi, Mehrdad; Hushmandi, Kiavash; Makvandi, Pooyan; Nazarzadeh Zare, Ehsan; Sharifi, Esmaeel; Goel, Arul; Wang, Lingzhi ; Ren, Jun; Nuri Ertas, Yavuz; Kumar, Alan Prem ; Wang, Yuzhuo; Rabiee, Navid; Sethi, Gautam ; Ma, Zhaowu
851-Sep-2021New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilitiesAshrafizadeh, Milad; Mirzaei, Sepideh; Hashemi, Farid; Zarrabi, Ali; Zabolian, Amirhossein; Saleki, Hossein; Sharifzadeh, Seyed Omid; Soleymani, Leyla; Daneshi, Salman; Hushmandi, Kiavash; Khan, Haroon; Kumar, Alan Prem ; Aref, Amir Reza; Samarghandian, Saeed
862018NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistanceMonisha J.; Roy N.K.; Padmavathi G.; Banik K.; Bordoloi D.; Khwairakpam A.D.; Arfuso F.; Chinnathambi A.; Alahmadi T.A.; Alharbi S.A.; Sethi G. ; Kumar A.P. ; Kunnumakkara A.B.
87Apr-2012NHE-1: A promising target for novel anti-cancer therapeuticsLoo, S.Y.; Chang, M.K.X.; Chua, C.S.H.; Kumar, A.P. ; Pervaiz, S.; Clement, M.V. 
882015Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patientsDai X.; Ahn K.S.; Kim C.; Siveen K.S. ; Ong T.H.; Shanmugam M.K. ; Li F.; Shi J. ; ALAN PREM KUMAR ; Wang L.Z. ; Goh B.C. ; Magae J.; Hui K.M.; Sethi G. 
892018Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cellsMohan, C.D; Anilkumar, N.C; Rangappa, S; Shanmugam, M.K ; Mishra, S ; Chinnathambi, A; Alharbi, S.A; Bhattacharjee, A; Sethi, G ; Kumar, A.P ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S
902016Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.Kumavath, Ranjith; Azad, Manan; Devarapalli, Pratap; Tiwari, Sandeep; Kar, Shreya; Barh, Debmalya; Azevedo, Vasco; Kumar, Alan Prem 
912015Novel phospholipase A2 inhibitors from python serum are potent peptide antibioticsSamy, Ramar Perumal Erumal ; Thwin, Maung Maung Aung; Stiles, Bradley G; Satyanarayana-Jois, Seetharama; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali Li; Siveen, Kodappully Sivaraman ; Sikka, Sakshi; ALAN PREM KUMAR ; Sethi, Gautam ; Lim, Hsiu Kim Lina 
1226-Feb-2021Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discoveryMirzaei, Sepideh; Zarrabi, Ali; Hashemi, Farid; Zabolian, Amirhossein; Saleki, Hossein; Azami, Negar; Hamzehlou, Soodeh; Farahani, Mahdi Vasheghani; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem 
132007Oxidative repression of NHE1 gene expression involves iron-mediated caspase activityKumar, A.P. ; Chang, M.K.X. ; Clement, M.-V. ; Fliegel, L.; Pervaiz, S. 
1411-Dec-2020Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorWang, Yanxin; Chiou, Yi-Shiou; Chong, Qing-Yun ; Zhang, Mengyi; Rangappa, Kanchuragoppal S; Ma, Lan; Zhu, Tao; Kumar, Alan Prem ; Huang, Ruby Yun-Ju ; Pandey, Vijay; Basappa; Lobie, Peter E
152019Pharmacological inhibition of TFF3 enhances sensitivity of CMS4 colorectal carcinoma to 5-fluorouracil through inhibition of p44/42 MAPKChen, R.-M. ; Chiou, Y.-S.; Chong, Q.-Y. ; Poh, H.-M.; Tan, T.-Z. ; Zhang, M.-Y.; Ma, L.; Zhu, T.; Pandey, V.; Salundi, B.; Prem Kumar, A. ; Lobie, P.E. 
1624-Mar-2022PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer ProgressionDeng, Shuo ; Leong, Hin Chong ; Datta, Arpita ; Gopal, Vennila; Kumar, Alan Prem ; Yap, Celestial T 
171-Dec-2023PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerGlaviano, A; Foo, ASC; Lam, HY ; Yap, KCH ; Jacot, W; Jones, RH; Eng, H ; Nair, MG; Makvandi, P; Geoerger, B; Kulke, MH; Baird, RD; Prabhu, JS; Carbone, D; Pecoraro, C; Teh, DBL; Sethi, G ; Cavalieri, V; Lin, KH; Javidi-Sharifi, NR; Toska, E; Davids, MS; Brown, JR; Diana, P; Stebbing, J; Fruman, DA; Kumar, AP 
1817-Feb-2021Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentChai, Yuek Ling ; Chong, Joyce R ; Raquib, Ainiah R ; Xu, Xin ; Hilal, Saima ; Venketasubramanian, Narayanaswamy; Tan, Boon Yeow ; Kumar, Alan P ; Sethi, Gautam ; Chen, Christopher P ; Lai, Mitchell KP 
191-Sep-2011Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4Manu, K.A. ; Shanmugam, M.K. ; Rajendran, P.; Li, F.; Ramachandran, L.; Hay, H.S. ; Kannaiyan, R.; Swamy, S.N.; Vali, S.; Kapoor, S.; Ramesh, B.; Bist, P.; Koay, E.S.; Lim, L.H.K.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.
202020Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activityAshrafizadeh, M.; Zarrabi, A.; Hashemi, F.; Zabolian, A.; Saleki, H.; Bagherian, M.; Azami, N.; Bejandi, A.K.; Hushmandi, K.; Ang, H.L.; Makvandi, P.; Khan, H.; Kumar, A.P.